OS Animal Health is a wholly owned subsidiary of OS Therapies Inc. (NYSE American: OSTX) dedicated to improving outcomes for pets with cancer. The company is focused on developing and commercializing OST-HER2 for canine osteosarcoma and is working to re-establish USDA conditional approval to bring innovative immunotherapies to the veterinary oncology market. OST-HER2 is being positioned as the “go-to” option for all HER2 positive cancers in dogs, and eventually for all companion animals. For more information, visit the company’s website at: https://ostherapies.com/
To register to attend, visit: https://moodycapital.com/conference/
To view IBN’s coverage of the conference, visit https://ibn.fm/MoodyCapital2026Conference
About Moody Capital Solutions Inc.
Moody Capital Solutions is an independent, full-service investment bank with more than 40 years of experience in capital raising, M&A, and advisory services, and is recognized as a market leader in rights offerings. Member FINRA/SIPC. www.moodycapital.com
About IBN’s Coverage
IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://ibn.ai/
Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
IBN.Ai
Austin, Texas
www.IBN.Ai
512.354.7000 Office
Editor@IBN.Ai
OS Therapies Contact Information:
Investor Relations
Harrison Seidner, PhD
WaterSeid Partners
OSTX@waterseid.com
https://x.com/OSTherapies
https://www.instagram.com/ostherapies/
https://www.facebook.com/OSTherapies/
https://www.linkedin.com/company/os-therapies/
